Skip to main content
Equibles
GENB logo

GENB · Generate Biomedicines, Inc. · Debt

Track GENB — free

Use GENB with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research GENB.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$13.06 +0.49 (+3.90%) At close · Nov 6
Russell 2000 member Rebalance outlook locked
Going-concern doubt — cleared Aug 6, 2026

The latest filing states the doubt was alleviated.

“As of December 31, 2025, the Company had concluded that there was substantial doubt about its ability to continue as a going concern. Upon closing of the IPO and receipt of the associated cash proceeds, the Company has alleviated the substantial doubt that previously existed, and based on the Company’s current capital resources, which consists of its cash, cash equivalents and marketable securities on hand at June 30, 2026, it expects to have sufficient cash to fund our current operating plan into the first half of 2028.”
View the 10-Q filed Aug 6, 2026
Market Cap
$1.68B
Shares
128.35M
Volume · Nov 6 632.2K Avg daily vol (3M) 1.2M

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Read debt and covenant terms in your AI or your code through MCP and the API →

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Current finance lease liabilities 2026-06-30 USD 3,744,000 10-Q filed 2026-08-06
Current operating lease liabilities 2026-06-30 USD 9,875,000 10-Q filed 2026-08-06
Noncurrent finance lease liabilities 2026-06-30 USD 1,366,000 10-Q filed 2026-08-06
Noncurrent operating lease liabilities 2026-06-30 USD 47,643,000 10-Q filed 2026-08-06
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Key facts CIK 2100782 CUSIP 370920100 13F (30d) 35 filings 35 filers Visit website Investor relations